These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 17951320

  • 1. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 2. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [Abstract] [Full Text] [Related]

  • 3. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 4. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C, Preusch MR, Hofmann G, Morris-Rosenfeld S, Blessing E, Rosenfeld ME, Katus HA, Bea F.
    Cardiovasc Res; 2010 May 01; 86(2):321-9. PubMed ID: 20110335
    [Abstract] [Full Text] [Related]

  • 5. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y.
    Cardiovasc Res; 2009 May 01; 82(2):371-81. PubMed ID: 19176597
    [Abstract] [Full Text] [Related]

  • 6. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):223-9. PubMed ID: 15047172
    [Abstract] [Full Text] [Related]

  • 7. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW.
    Arterioscler Thromb Vasc Biol; 2010 Apr 23; 30(4):742-8. PubMed ID: 20110573
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
    Muñoz-García B, Moreno JA, López-Franco O, Sanz AB, Martín-Ventura JL, Blanco J, Jakubowski A, Burkly LC, Ortiz A, Egido J, Blanco-Colio LM.
    Arterioscler Thromb Vasc Biol; 2009 Dec 23; 29(12):2061-8. PubMed ID: 19778942
    [Abstract] [Full Text] [Related]

  • 9. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.
    Circulation; 2007 Sep 18; 116(12):1404-12. PubMed ID: 17724261
    [Abstract] [Full Text] [Related]

  • 10. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2006 Aug 18; 26(8):1858-63. PubMed ID: 16763157
    [Abstract] [Full Text] [Related]

  • 11. Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice.
    Weng S, Zemany L, Standley KN, Novack DV, La Regina M, Bernal-Mizrachi C, Coleman T, Semenkovich CF.
    Proc Natl Acad Sci U S A; 2003 May 27; 100(11):6730-5. PubMed ID: 12746502
    [Abstract] [Full Text] [Related]

  • 12. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S, Gijbels MJ, van der Made I, Mujcic H, Thelen M, Vergouwe MN, Ambagts MH, Hofker MH, de Winther MP.
    Cardiovasc Res; 2008 Nov 01; 80(2):309-18. PubMed ID: 18628255
    [Abstract] [Full Text] [Related]

  • 13. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R, Hojjati MR, Devlin CM, Hansen IH, Jiang XC.
    Arterioscler Thromb Vasc Biol; 2007 Jan 01; 27(1):190-6. PubMed ID: 17038631
    [Abstract] [Full Text] [Related]

  • 14. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M, Sanz-González SM, Abu Nabah YN, Lamana A, Sánchez-Madrid F, Andrés V.
    Cardiovasc Res; 2009 Jan 01; 81(1):197-205. PubMed ID: 18703531
    [Abstract] [Full Text] [Related]

  • 15. Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.
    Canault M, Peiretti F, Poggi M, Mueller C, Kopp F, Bonardo B, Bastelica D, Nicolay A, Alessi MC, Nalbone G.
    J Pathol; 2008 Apr 01; 214(5):574-83. PubMed ID: 18247429
    [Abstract] [Full Text] [Related]

  • 16. Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis.
    Preusch MR, Rattazzi M, Albrecht C, Merle U, Tuckermann J, Schütz G, Blessing E, Zoppellaro G, Pauletto P, Krempien R, Rosenfeld ME, Katus HA, Bea F.
    Arterioscler Thromb Vasc Biol; 2008 Dec 01; 28(12):2158-64. PubMed ID: 18787189
    [Abstract] [Full Text] [Related]

  • 17. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.
    Arterioscler Thromb Vasc Biol; 2014 Apr 01; 34(4):790-800. PubMed ID: 24526691
    [Abstract] [Full Text] [Related]

  • 18. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
    Jeon HJ, Choi JH, Jung IH, Park JG, Lee MR, Lee MN, Kim B, Yoo JY, Jeong SJ, Kim DY, Park JE, Park HY, Kwack K, Choi BK, Kwon BS, Oh GT.
    Circulation; 2010 Mar 09; 121(9):1124-33. PubMed ID: 20176988
    [Abstract] [Full Text] [Related]

  • 19. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 09; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 20. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR, Yancey PG, Ryzhov SV, Kon V, Breyer MD, Magnuson MA, Fazio S, Linton MF.
    Arterioscler Thromb Vasc Biol; 2005 Aug 09; 25(8):1647-53. PubMed ID: 15947238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.